GlobeNewswire 10.06.2025 Axsome Therapeutics Announces Availability of SYMBRAVO® (meloxicam and rizatriptan) for the Acute Tr...
GlobeNewswire 05.06.2025 Diginex Limited Signs MOU to Acquire Resulticks for US$2bn, transforming AI and Data Management Capa...
GlobeNewswire 04.06.2025 ROHM Develops Breakthrough AI-Equipped MCU
GlobeNewswire 20.05.2025 EverCommerce Appoints Amy Guggenheim Shenkan to Its Board of Directors
GlobeNewswire 15.05.2025 Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2025 and Provides Bu...
GlobeNewswire 14.05.2025 BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Par...
GlobeNewswire 07.05.2025 BioVie to Present Rationale and Design of Phase 2 SUNRISE-PD Clinical Trial at the 30th World Congre...
GlobeNewswire 05.05.2025 BioVie Unveils Corporate Advisory Board Featuring Neuralink Co-Founder, Former Executives from Maste...
GlobeNewswire 05.05.2025 Regeneration Biomedical to Present Updated Phase 1 Trial Data on Autologous Stem Cell Therapy Inject...
GlobeNewswire 22.04.2025 Zurab Tsereteli, Internationally Acclaimed Artist and Friend of Wolf Popper LLP, Dies at 91
GlobeNewswire 16.04.2025 BioVie Initiates SUNRISE-PD Clinical Trial Assessing Bezisterim in Early Parkinson’s Disease with Fi...
GlobeNewswire 15.04.2025 Radiance Announces First Patient Dosing in Phase 1 Clinical Trial of its Next Generation ROR-1 Targe...
GlobeNewswire 15.04.2025 Scilex Holding Company Announces Approval of a New Drug Submission (NDS) from the Health Canada’s Ph...
GlobeNewswire 01.04.2025 REPEAT -- Radiance Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of RB-164...
GlobeNewswire 01.04.2025 Sky Quarry Reports 4th Quarter and Fiscal Year 2024 Financial Results
GlobeNewswire 31.03.2025 Radiance Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of RB-164™, an ROR-...
GlobeNewswire 25.03.2025 Comstock Settles Strategic Commitments and Strengthens Balance Sheet
GlobeNewswire 19.03.2025 Comstock Announces 2025 Annual Meeting and Record Date
GlobeNewswire 13.03.2025 Modat launches premier product, Modat Magnify for Cybersecurity Professionals
GlobeNewswire 06.03.2025 Comstock Announces Full Year 2024 Results
GlobeNewswire 28.02.2025 Comstock Fuels Completes Financing with Marathon Petroleum
GlobeNewswire 27.02.2025 Comstock Inc. to Host Q4 Earnings Call and Business Update on March 6th at 4:30pm ET
GlobeNewswire 24.02.2025 Axsome Therapeutics Announces SYMBRAVO® (meloxicam and rizatriptan) Achieves Primary Endpoint in the...
GlobeNewswire 20.02.2025 Comstock Fuels Expands RenFuel Partnership
GlobeNewswire 19.02.2025 Radiance Biopharma Enters Exclusive License For ROR-1 Targeted Antibody Drug Conjugate